Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 77,63 € (+19,89 %). La mediana es de 74,21 € (+14,61 %).
| Comprar |
13 |
| Mantener |
10 |
| Vender |
0 |
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
Stifel Financial hits 52-week low at $67.95 despite strong quarterly results
Stifel Financial’s stock fell to a 52-week low of $67.95 and is currently trading near $67.89, giving it a market capitalization of about $10.45 billion. The shares have lost roughly 17.8% over six months and 16.2% year-to-date. At the same time, the company reported strong Q1 results with operating earnings per share of $1.45, revenue up 18% to $1.48 billion, assets under management of $579.7 billion and a dividend of $0.34 per share; analysts see valuation metrics suggesting undervaluation. » Más en de.investing.com
Stifel Financial announces quarterly dividend of $0.34
Stifel Financial declared a cash dividend of $0.34 per common share, payable on June 15, 2026 to shareholders of record on June 1, 2026. The board also confirmed quarterly dividends for three series of preferred stock (Series B, C and D) with respective distributions of approximately $0.390625, $0.3828125 and $0.28125 per depositary share. The dividend reflects the company’s nine years of rising payouts; the current yield is 1.73 percent. Investor note: the preferred dividends cover the period from March 16 to June 15, 2026. » Más en de.investing.com
Stifel exceeds Q1 2026 expectations on earnings and revenue, stock slightly under pressure
Stifel reports adjusted EPS of $1.45 for Q1 2026 (expectation $1.37) and revenue of $1.48bn (expectation $1.44bn), driven by strong investment banking fees. Despite the positive results, the stock fell 0.38% in pre-market trading to $81.96. Management highlights company-wide AI initiatives and venture lending as growth drivers and reaffirms a positive outlook with EPS guidance between $1.46 and $2.09 and expected Q2 revenue of about $1.47bn. Risks remain from market volatility, geopolitical tensions and interest-rate uncertainty. » Más en de.investing.com
Acumen Pharmaceuticals presents Sabirnetug strategy at Stifel forum
Acumen Pharmaceuticals provided a strategic overview of Sabirnetug, which targets toxic, soluble Aβ oligomers in Alzheimer’s. The phase 2 ALTITUDE‑AD study with 542 recruits was completed in 10 months; results are expected at the end of 2026 and are seen as key to validating the Aβ oligomer hypothesis. The company is collaborating with JCR Pharmaceuticals to improve brain uptake using IZCARGO and aims to file an IND for the EBD program by mid‑2027. Acumen remains open to partnerships for phase 3 development, depending on the ALTITUDE‑AD results; the subcutaneous formulation will continue to be evaluated. » Más en de.investing.com
Stifel Financial beats Q4-2025 forecasts, announces stock split and dividend increase
Stifel Financial reported Q4 2025 earnings per share of $2.63 (expectation $2.51) and revenue of $1.56 billion (expectation $1.5 billion). Management announced a 3-for-2 stock split and an 11% dividend increase. For 2026, net revenue is expected between $6.0 billion and $6.35 billion; 2025 was a record year with $5.5 billion. Despite the positive results, the stock moved little in premarket trading, and the company continues to show strong margins and a high return on tangible equity. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | septiembre de 2026 | YoY |
|---|---|---|
| Ingresos | 1443,61 M | 4,66 % |
| Beneficio bruto | 1247,19 M | 4,15 % |
| Beneficio neto | 206,71 M | 14,77 % |
| EBITDA | 280,37 M | 7,11 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 9650,86 M € |
Número de acciones | 149,24 M |
Máximo/mínimo de 52 semanas | 81,80 € - 59,55 € |
Rentabilidad por dividendo | 1,93 % |
Dividendos TTM | 1,27 € |
Próximo dividendo | 0,31 € |
Beta | 1,02 |
Ratio P/E | 10,25 |
Ratio PEG | 0,70 |
Ratio P/B | 1,78 |
Ratio P/S | 1,58 |
Perfil de la empresa
Stifel Financial Corp., una sociedad de cartera de servicios financieros y bancarios, ofrece servicios de gestión de patrimonios minoristas e institucionales, y banca de inversión a inversores particulares, empresas, municipios e instituciones en Estados Unidos, el Reino Unido, el resto de Europa y Canadá. Opera en tres segmentos: Global Wealth Management, Institutional Group y Otros. La compañía presta servicios a clientes privados, entre ellos servicios de transacciones con valores y planificación financiera; ventas, negociación e investigación de renta variable y renta fija institucional, así como servicios de financiación municipal; servicios de banca de inversión, como fusiones y adquisiciones, ofertas públicas y colocaciones privadas; y servicios de banca minorista y comercial que comprenden programas de préstamos personales y comerciales, así como cuentas de depósito. También participa en y gestiona suscripciones de emisiones para la financiación corporativa y pública, y ofrece servicios de asesoramiento financiero y de corretaje de valores. La compañía fue fundada en 1890 y tiene su sede en St. Louis, Misuri.
| Nombre | Stifel Financial Co. |
| CEO | Ronald James Kruszewski |
| Sede | Saint Louis,
mo Estados Unidos |
| Sitio web | |
| Sector | Finanzas |
| Industria | Servicios financieros |
| Salida a bolsa | 19/07/1983 |
| Empleados | 8900 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | SF |
Frankfurt | 2SI.F |
Düsseldorf | 2SI.DU |